Press release
Migraine Drugs Market is expected to grow at a CAGR of 3.1% during period 2018-2025
Increase in prevalence of migraine, rapid rise in female population, and surge in awareness among patients for migraine treatment & prevention drive the growth of the global migraine drugs market. However, side effects of migraine drugs are expected to limit the market growth.
Conversely, emerging new therapies/drugs for migraine treatment and growth opportunities in the emerging nations are expected to present opportunities for the market growth during the forecast period.
Download Report Sample: https://www.alliedmarketresearch.com/request-sample/2811?utm_source=openpr&utm_medium=ss
According to a new report published by Allied Market Research, the market was valued at $1,713 million in 2017, and is expected to reach $2,190 million by 2025, growing at a CAGR of 3.1% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period.
North America was the leading revenue contributor to the global market in 2017, owing to surge in demand for better healthcare along with effective government reforms for awareness towards migraine & its prevention.
However, Asia-Pacific is expected to grow at the highest CAGR of 4.4% from 2018 to 2025, due to improvements in healthcare infrastructure and rise in demand for better healthcare facilities.
Make a Purchase Enquiry of Report: https://www.alliedmarketresearch.com/purchase-enquiry/2811?utm_source=openpr&utm_medium=ss
Market Players:
• Abbott Laboratories
• Pfizer Inc.
• Allergan Plc.
• AstraZeneca
• Eisai Co.Ltd.
• Endo International Plc.
• GlaxoSmithKline Plc.
• Impax Laboratories
• Johnson & Johnson
• Merck & Co.
Market Segmented By:
• Type
• Route of Administration
• Distribution Channel
• Region
Key Benefits:
• This report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities along with strategic assessment of the global migraine drugs market.
• Migraine drugs market size and estimations are based on comprehensive analysis of the applications and developments in the industry.
• A qualitative analysis based on innovative products and devices facilitate the strategic business planning.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the migraine drugs industry.
Browse Full Report with TOC: https://www.alliedmarketresearch.com/migraine-drugs-market?utm_source=openpr&utm_medium=ss
About Us:
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
Contact:
Sona Padman
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Migraine Drugs Market is expected to grow at a CAGR of 3.1% during period 2018-2025 here
News-ID: 1479975 • Views: …
More Releases from Allied Market Research
Missile Defense System Market Is Anticipated To Project Robust Growth With A CAG …
The Global Missile defense system market size was valued at $26.16 billion in 2020, and is projected to reach $40.04 billion by 2030, registering a CAGR of 4.4% from 2021 to 2030.
Download Sample Pages : https://www.alliedmarketresearch.com/request-sample/A11299
Rise in number of conflicts throughout the world and surge in defense spending globally are expected to drive the missile defense system market during the forecast period. However, high cost associated with the missile defense…
Exploring the Recent Waves of Innovation, Mergers, and Emerging Trends in the Wa …
The global walnut oil industry was generated $925.4 million in 2022, and is anticipated to generate $1,718.8 million by 2032, rising at a CAGR of 6.6% from 2023 to 2032.
The growing usage of walnut oil as a die tary supplement and the rising preference of people for vegan snacks along with the increasing popularity of plant-based diets are the factors expected to drive the growth of the global walnut oil…
Endpoint Security Market Size Growing at 8.4% CAGR Reach USD 31.9 Billion by 203 …
Allied Market Research published a new report, titled, "Endpoint Security Market Size Growing at 8.4% CAGR Reach USD 31.9 Billion by 2031." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain a thorough understanding of the industry and determine…
Smart Manufacturing Market Size Growing at 13.7% CAGR Reach USD 860 Billion by 2 …
Allied Market Research published a new report, titled, "Smart Manufacturing Market Size Growing at 13.7% CAGR Reach USD 860 Billion by 2031." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segments, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain a thorough understanding of the industry and determine…
More Releases for Migraine
Leading Growth Driver in the Migraine Market Share in 2025: Rising Prevalence Of …
What Market Share dynamics are playing a key role in accelerating the growth of the migraine Market Share?
The migraine Market Share is projected to grow, driven by the rising occurrence of migraines. Migraines, a kind of headache that typically affects one side of the brain and causes intense, throbbing pain or a pulsing sensation, can be managed and relief can be provided via proper treatment. This treatment paves the way…
Emerging Acute Migraine Treatment Market Trend 2025-2034: Innovative CGRP Recept …
How Is the Acute Migraine Treatment Market Projected to Grow, and What Is Its Market Size?
The market size for acute migraine treatment has witnessed substantial growth in the past few years. Forecasts expect it to expand from $2.6 billion in 2024 to $2.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth in the historical period include the rising incidence of migraines,…
Key Influencer in the Migraine Market 2025: Rising Prevalence Of Migraine Drives …
"What Is the Forecasted Market Size and Growth Rate for the Migraine Market?
The migraine market is projected to grow steadily from $1.93 billion in 2024 to $1.97 billion in 2025, at a CAGR of 2.2%. This growth is attributed to the rising prevalence of migraines, growing awareness of treatment options, government initiatives, increased alcohol consumption, and lifestyle changes.
Migraine Market: Expected to grow to $2.25 billion by 2029 at a CAGR…
How Big is Migraine Drugs Market?
In 2022, the Global Migraine Drugs Market soared to USD 10,972.1 million, marking a significant milestone. Projections indicate a promising trajectory, with expectations set for substantial growth, potentially reaching USD 26,618.96 million by 2031. Forecasts for the period between 2024 and 2031 suggest a robust Compound Annual Growth Rate (CAGR) of 12.1% for the migraine drugs market.
The objectives outlined in the report are multifaceted and aimed at offering a comprehensive…
Migraine Therapeutics Market - Relieve the Burden: Empowering Lives through Migr …
Newark, New Castle, USA - new report, titled Migraine Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Migraine Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Migraine Therapeutics market. The report offers an overview of the market, which…
Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025
Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases.
The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs.
Get Access to TOC /…
